CYP2D6型
去异喹
等位基因
右美沙芬
遗传学
基质(水族馆)
生物
药物遗传学
基因
基因型
药理学
生态学
作者
Maaike van der Lee,Henk‐Jan Guchelaar,Jesse Joachim Swen
出处
期刊:Pharmacogenomics
[Future Medicine]
日期:2021-09-27
卷期号:22 (16): 1081-1089
被引量:24
标识
DOI:10.2217/pgs-2021-0093
摘要
Genetic variation in the gene encoding CYP2D6 is used to guide drug prescribing in clinical practice. However, genetic variants in CYP2D6 show substrate-specific effects that are currently not accounted for. With a systematic literature, we retrieved 22 original studies describing in vitro experiments focusing on CYP2D6 alleles (CYP2D6*1, *2, *10 and *17) and substrates. Allele activity (clearance of the allele of interest divided by the clearance of the wildtype) was extracted. The results support the hypothesis of the existence of substrate specificity of the CYP2D6*17-allele (higher debrisoquine clearance), a subtle effect of the CYP2D6*10-allele (lower dextromethorphan clearance) but no substrate-specific effect of the CYP2D6*2-allele. Although our results support substrate specificity, for most substrates data are too sparse and require further studies.
科研通智能强力驱动
Strongly Powered by AbleSci AI